|
Market Closed -
Nasdaq Stockholm
09:30:00 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.570 SEK | +5.00% |
|
+28.42% | +142.86% |
Company Valuation: Sprint Bioscience AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 191.1 | 22.03 | 121.1 | 110.5 | 155.1 | 376.7 | - |
| Change | - | -88.47% | 449.78% | -8.82% | 40.43% | 142.86% | - |
| Enterprise Value (EV) | 120.4 | -7.459 | 71.2 | 85.4 | 155.1 | 376.7 | 376.7 |
| Change | - | -106.19% | 1,054.57% | 19.94% | 81.63% | 142.86% | 0% |
| P/E | -5.64x | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - |
| Capitalization / Revenue | 5.44x | 265x | 2.4x | 1.68x | 0.93x | 4.34x | 3.89x |
| EV / Revenue | 0x | -0x | 0x | 0x | 0x | 4.34x | 3.89x |
| EV / EBITDA | -0x | 0x | -0x | -0x | 0x | 14.1x | 9.78x |
| EV / EBIT | -0x | 0x | -0x | -0x | 0x | 14.7x | 10x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.85 | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 35.11 | 0.083 | 50.48 | 65.64 | 167.2 | 86.8 | 96.8 |
| EBITDA 1 | -25.04 | -60.12 | -0.398 | -18.71 | 98.36 | 26.8 | 38.5 |
| EBIT 1 | -25.63 | -60.74 | -0.845 | -19.67 | 97.29 | 25.7 | 37.5 |
| Net income | -25.08 | - | - | - | - | - | - |
| Net Debt | -70.64 | -29.49 | -49.93 | -25.06 | - | - | - |
| Reference price 2 | 4.795 | 0.553 | 1.735 | 1.582 | 1.470 | 3.570 | 3.570 |
| Nbr of stocks (in thousands) | 39,844 | 39,844 | 69,820 | 69,820 | 1,05,516 | 1,05,516 | - |
| Announcement Date | 16/02/22 | 15/02/23 | 14/02/24 | 12/02/25 | 11/02/26 | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.75Cr | |
| 21.73x | 7.77x | 15.61x | 1.37% | 7.44TCr | |
| 31.25x | 9.01x | 28.06x | 0.04% | 5.93TCr | |
| 33.64x | 6.03x | 18.07x | 0.97% | 4.71TCr | |
| 34.63x | 3.34x | 14.4x | -.--% | 4.29TCr | |
| -21.16x | 229.18x | -22.81x | -.--% | 4.41TCr | |
| 47.94x | 5.54x | 30.43x | -.--% | 4.08TCr | |
| 26.89x | 7.76x | 19.96x | 0.42% | 3.08TCr | |
| 33.91x | 7.26x | 18.84x | -.--% | 2.93TCr | |
| -70.02x | 13.44x | -68.51x | -.--% | 2.37TCr | |
| Average | 15.42x | 32.15x | 6.01x | 0.31% | 3.92TCr | |
| Weighted average by Cap. | 19.68x | 32.23x | 10.37x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SPRINT Stock
- Valuation Sprint Bioscience AB
Select your edition
All financial news and data tailored to specific country editions
